Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1998-06-15
2000-07-18
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241451, 4241581, 435 71, 435 723, 5303873, 53038823, 53038824, 5303892, A61K 3940, A61K 39395, G01N 33574, C12P 2108, C07K 1600
Patent
active
06090383&
ABSTRACT:
Monoclonal antibodies to transforming growth factor beta (TGF-B) are prepared from hybrid cell lines by immunizing with TGF-B2. The antibodies may be of any isotype and may be of any mammalian origin such as murine or human origin. Therapeutic applications utilizing the TGF-B monoclonal antibody are also disclosed.
REFERENCES:
patent: 4774322 (1988-09-01), Seyedin et al.
patent: 5262319 (1993-11-01), Iwata et al.
patent: 5571714 (1996-11-01), Dasch et al.
patent: 5772998 (1998-06-01), Dasch et al.
patent: 5783185 (1998-07-01), Dasch et al.
Ellingsworth, et al., "Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor.beta." J. Biol. Chem. (1986) 261:12362-12367.
Ellingsworth, et al., "Transforming growth factor-.beta.s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation" Cellular Immunology (1988) 114:41-54.
Flanders, et al., "Antibodies to peptide determinants in transforming growth factor .beta. and their applications" Biochemistry (1988) 27:739-746.
Galfre, et al., "Preparation of monoclonal antibodies: strategies and procedures" Methodin Enzymology (1981) 73:3-46.
Han, et al., "Megakaryocytopoiesis: characterization and regulation in normal and pathologic states" Int. J. Hematol. (1991) 54(1):3-14.
Harris, et al., "Therapeutic antibodies--the coming of age" TIBTECH (1993) 11:42-44.
Hatzfeld, et al., "Release of early human hematopoietic progenitors form quiescence by antisense transforming growth factor .beta.1 or Rb oligonucleotides" J. Exp. Med. (1991) 174:925-929.
Hayashi, et al., "Differential effects of TGF-.beta..sub.1 on lymphohemopoiesis in long-term bone marrow cultures" Blood (1989) 74(5):1711-1717.
Herlyn, et al., "Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro" Adv. Cancer Res. (1990) 54:213-234.
Ishibashi, et al., "Type .beta. transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro" Blood (1987) 69:1737-1741.
Jordan, et al., "Cellular and developmental properties of fetal hematopoietic stem cells" Cell (1990) 61:953-963.
Kehrl, et al., "Production of transforming growth factor-.beta. by human T lymphocytes and its potential role of the regulation of T cell growth" J. Exp. Med. (1986) 163:1037-1050.
Kehrl, et al., "Transforming growth factor .beta. is an important immunomodulatory protein for human B lymphocytes" J. Immunol. (1986) 137:3855-3860.
Keller, et al., "Transforming growth factor .beta.-1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines" J. Exp. Med. (1988) 168:737-750.
Keller, et al., "Transforming growth factor .beta. directly regulates primitive murine hematopoietic cell proliferation" Blood (1990) 75:596-602.
Keski-Oja, et al., "Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-.beta..sup.1 "Cancer Research(1987) 47:6451-6458.
Lee, et al., ".beta. transforming growth factors are potential regulators of B lymphopoiesis" J. Exp. Med. (1987) 166:1290-1299.
Lucas, et al., "The autocrine production of transforming growth factor-.beta..sub.1 during lymphocyte activation" J. Immunol. (1990) 145(5):1415-1422.
Massague, "The TFG-.beta. family of growth and differentiation factors" Cell (1987) 49:437-438.
Ohta, et al., "Two forms of transforming growth factor-.beta. distinguished by multipotential hematopoietic progenitor cells" Nature (1987) 329:539-541.
Ranges, et al., "Inhibition of cytotoxic T cell development by transforming growth factor .beta. and reversal by recombinant tumor necrosis factor alpha" J. Exp. Med. (1987) 166:991-998.
Roberts, et al., "Type .beta. transforming growth factor: a bifunctional regulator of cellular growth" Proc. Natl. Acad. Sci. USA (1985) 82:119-123.
Rook, et al., "Effects of transforming growth factor .beta. on the functions of natural killer cells depressed cytolytic activity and blunting of interferon responsiveness" J. Immunol. (1986) 136:3916-3920.
Rosa, et al., "Mesoderm induction in amphibians the role of TGF-.beta.-2-like factors" Science (1988) 239:783-785.
Seyedin, et al., "Cartilage-inducing factor .beta. is a unique protein structurally and functionally related to transforming growth factor-.beta." J. Biol. Chem. (1987) 262:1946-1949.
Sing, et al., "Transforming growth factor .beta. selectively inhibits normal and leukemic human bone marrow cell growth in-vitro" Blood (1988) 72(5):1504-1511.
Waegell, et al., "Neutralizing antibody to TGF-.beta. overcomes normal growth controls in long-term bone marrow cultures"J. Cell. Biochem. (1992) 16:92 (abstract no. M342).
Waegell, et al., "Growth acceleration and stem cell expansion in Dexter-type cultures by naturalization of TGF-.beta." Experimental Hematology (1994) 22:1051-1057.
Wahl, et al., "Transforming growth factor type .beta. induces monocyte chemotaxis and growth factor production" Proc. Natl. Acad. Sci. USA (1987) 84:5788-5792.
Wang, et al., "Expression cloning and characterization of the TGF-.beta. type III receptor"Cell(1991) 67:797-805.
Publication distributed by R & D Systems, Inc., identified as vol. 1, No. 1, and dated Jan. 1987.
Berenson, et al., "Engraftment after infusion of CD34.sup.+ marrow cells in patients with breast cancer or neuroblastoma" Blood (1991) 77:1717-1722.
Carlino, et al., "Transforming growth factor .beta.1 systematically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice" Exp. Hematol. (1992) 20:943-950.
Cashman, et al., "Mechanisms that regulate the cell cycle of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-.beta." Blood (1990) 75(1):96-101.
Cheifetz, et al., "The transforming growth factor-.beta. system: A complex pattern of cross-reactive ligands and receptors" Cell (1987) 48:409-416.
Dasch, et al., "Monoclonal Antibodies Recognizing Transforming Growth Factor-.beta.:Bioactivity Neutralization and Transforming Growth Factor-.beta..sub.2 Affinity Purification", J. Immunol. (1989) 142(5):1536-1547.
Durametal, "Proinflammatory Cytokines and Immunity"in Fundamental Immunology, 3rd Ed., Paulm W.E., Ed. Raven Press, Ltd., New York (1993).
Eaves, et al., "Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer" Blood (1991) 78(1):110-117.
Science, 262, 841-843 1993.
Dasch James R.
Pace, III Doran R.
Waegell Wendy O.
Hutzell Paula K.
Sun-Hoffman Lin
LandOfFree
Monoclonal antibodies to transforming growth factor-.beta. and m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to transforming growth factor-.beta. and m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to transforming growth factor-.beta. and m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2033699